NuVasive Update on COALESCE, COHERE Interbody Fusion Devices

NuVasive (NUVA) launched the COALESCE™ Thoracolumbar Interbody Fusion device, and announced FDA 510(k) clearance to market the COHERE® Cervical Interbody Fusion Device with expanded indications. NUVA gained ownership of these systems with its 3Q17 acquisition of Vertera Spine.

The devices join Modulus® Titanium interbodies in NUVA's Advanced...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us